ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Eagle Point Credit Company Inc

Eagle Point Credit Company Inc (ECCV)

22.62
0.17
(0.76%)
Closed June 29 4:00PM
22.62
0.00
(0.00%)
After Hours: 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
22.62
Bid
-
Ask
-
Volume
932
22.46 Day's Range 22.62
21.0301 52 Week Range 22.94
Market Cap
Previous Close
22.45
Open
22.50
Last Trade
100
@
22.62
Last Trade Time
Financial Volume
$ 20,990
VWAP
22.5217
Average Volume (3m)
4,950
Shares Outstanding
60,662,524
Dividend Yield
5.94%
PE Ratio
11.60
Earnings Per Share (EPS)
1.93
Revenue
139.07M
Net Profit
116.89M

About Eagle Point Credit Company Inc

Eagle Point Credit Co Inc is a managed closed-end management investment company. The company's primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. Also, to achieve investment objectives by investing primarily in equity and jun... Eagle Point Credit Co Inc is a managed closed-end management investment company. The company's primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. Also, to achieve investment objectives by investing primarily in equity and junior debt tranches of collateralized loan obligations (CLOs). Show more

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Wilmington, Delaware, USA
Founded
1970
Eagle Point Credit Company Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker ECCV. The last closing price for Eagle Point Credit was $22.45. Over the last year, Eagle Point Credit shares have traded in a share price range of $ 21.0301 to $ 22.94.

Eagle Point Credit currently has 60,662,524 shares outstanding. The market capitalization of Eagle Point Credit is $1.36 billion. Eagle Point Credit has a price to earnings ratio (PE ratio) of 11.60.

ECCV Latest News

Eagle Point Credit Company Inc. Announces First Quarter 2024 Financial Results

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCF, ECCV, ECCW, ECCX) today announced financial results for the quarter ended March 31, 2024 and certain additional...

Eagle Point Credit Company Inc. Announces Third Quarter 2024 Regular and Supplemental Common Distributions and Preferred Distributions

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCF, ECCV, ECCW, ECCX) today is pleased to announce the declaration of distributions on shares of the Company’s common...

Eagle Point Credit Company Inc. Schedules Release of First Quarter 2024 Financial Results on Tuesday, May 21, 2024

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCF, ECCV, ECCW, ECCX) today announced that it plans to report financial results for the quarter ended March 31, 2024...

Eagle Point Credit Company Inc. Announces Fourth Quarter and Year-End 2023 Financial Results

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCF, ECCV, ECCW, ECCX) today announced financial results for the quarter and fiscal year ended December 31, 2023 and...

Eagle Point Credit Company Inc. Announces Second Quarter 2024 Regular and Supplemental Common Distributions and Preferred Distributions

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCF, ECCV, ECCW, ECCX) today is pleased to announce the declaration of distributions on shares of the Company’s common...

Eagle Point Credit Company Inc. Schedules Release of Fourth Quarter 2023 and Year-end 2023 Financial Results on Thursday, February 22, 2024

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCF, ECCV, ECCW, ECCX) today announced that it plans to report financial results for the quarter and fiscal year ended...

Eagle Point Credit Company Inc. Prices Offering of Preferred Stock

Eagle Point Credit Company Inc. (the “Company”) (NYSE:ECC, ECCC, ECC PRD, ECCV, ECCW, ECCX) today announced that it has priced an underwritten public offering of 1,400,000 shares of its 8.00...

Eagle Point Credit Company Inc. Announces Offering of Preferred Stock

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCV, ECCW, ECCX) today announced that it has commenced an underwritten public offering of its Series F Term Preferred...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.140.62277580071222.4822.6222.35404522.46739174CS
40.08940.3967936939122.530622.732522.35367622.56558944CS
120.251.1175681716622.3722.732522.17495022.45107227CS
260.120.53333333333322.522.9422.01481322.48235156CS
520.743.3820840950621.8822.9421.0301390022.18780316CS
156-1.89-7.7111383108924.5124.6720.22529622.89068571CS
260-1.89-7.7111383108924.5124.6720.22529622.89068571CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASNSActelis Networks Inc
$ 2.3599
(59.45%)
71.61M
COSMCosmos Health Inc
$ 1.05
(54.64%)
81.3M
LUCYInnovative Eyewear Inc
$ 0.5036
(52.61%)
364.85M
NNENano Nuclear Energy Inc
$ 23.43
(44.45%)
9.41M
NBSTWNewbury Street Acquisition Corporation
$ 0.0613
(39.32%)
19.62k
CINGCingulate Inc
$ 0.3152
(-46.03%)
2.57M
BTOGBit Origin Ltd
$ 2.88
(-45.86%)
3.39M
ACCDAccolade Inc
$ 3.598
(-43.69%)
18.09M
NXLNexalin Technologies Inc
$ 1.71
(-42.23%)
4.51M
APVOAptevo Therapeutics Inc
$ 0.3011
(-41.52%)
2.52M
LUCYInnovative Eyewear Inc
$ 0.507001
(53.64%)
356.92M
NVDANVIDIA Corporation
$ 124.3812
(0.32%)
248.1M
FFIEFaraday Future Intelligent Electric Inc
$ 0.513
(-14.50%)
189.18M
SQQQProShares UltraPro Short QQQ
$ 8.20
(0.86%)
142.65M
TSLATesla Inc
$ 196.72
(-0.35%)
82.53M

Discussion

View Full Feed
madeindet madeindet 5 minutes ago
You buying Koan?
EMGE
Rum_Tequila Rum_Tequila 6 minutes ago
well stated, and good question… I still think the Benzinga article gets published Monday, with an abbreviated followup article soon after FDA approval
RDGL
FeMike FeMike 6 minutes ago
Anyone know if the ASM will be recorded or transcribed? I have a family reunion starting at noon.

Senti usually has it transcribed and posted pretty quickly. Not sure if she’s planning on doing it this time too.
ASM
cjstocksup cjstocksup 7 minutes ago
https://x.com/DC_Draino/status/1806665414329405871
DSherman DSherman 7 minutes ago
Gee, despite what I own I secretly wish I had purchased more shares of aspl and wmt when they were both at the 2 buck level. Over the last 40-50+ years I’ve learned to go with my gut after research so I never have regrets. Coulda woulda shoulda is an excuse for one’s own decisions usually involving
MGON
pos_stock_hoarder pos_stock_hoarder 7 minutes ago
Have a cigar Bill and STFU.
boobb2 boobb2 7 minutes ago
DITTO
MCIC
cjstocksup cjstocksup 8 minutes ago
https://x.com/DC_Draino/status/1806671375186214953
1hunglo 1hunglo 8 minutes ago
RDGL-Vivos submits application to FDA to initiate Human Trials at Mayo Clinic.
RDGL
lager lager 9 minutes ago
With the action starting Thursday and leading up until the end of the day Friday, and closing at HOD, it points to this new week being potentially significant. There's got to be something in the pipeline for this to suddenly have all this attention/action. The new website hasn't been officially anno
MGON
Dead On Arrival Dead On Arrival 9 minutes ago
I was kidding Walter.
LWLG
thegoodnessparadox thegoodnessparadox 9 minutes ago
What's the reason? Why not 100 or 1000?
GNCP
Roman516 Roman516 10 minutes ago
This opinion is worthless and has no foundation of truth whatsoever.
In fact, Dr. Linda Liau and her team are growing at UCLA by leaps and bounds over the last 3 years.
Furthermore, Dr. Linda Liau and her team are continuing their researching multiple cancer types based on DCVAX-L. DCV
NWBO
cjstocksup cjstocksup 10 minutes ago
https://x.com/DC_Draino/status/1806684484906946806
cjstocksup cjstocksup 10 minutes ago
https://x.com/DC_Draino/status/1806688551926382743
cjstocksup cjstocksup 11 minutes ago
https://x.com/DC_Draino/status/1806704423059554655
Just the facts maam Just the facts maam 11 minutes ago
Thanks Silvr, your right, according to Russell the newly reconstituted indexes will take effect after the market close on 28 June 2024. it will be interesting when PPS breaks through resistance.
ANIP
halbroke1 halbroke1 11 minutes ago
SMCE $$$ THIS COULD GO PARABOLIC THE NEXT 2 WEEKS, 0.20-0.25 OR MORE IS NOT OUT OF THE QUESTION..OPINIONS...THANKS
SMCE
manibiotech manibiotech 11 minutes ago
We are almost half a decade from data lock . Only binary event market wants after data lock is submission and approval . From revenue standpoint FDA matters the most . We have no idea even about plans to submit to FDA , leave alone approval . That’s the part of reason for the SP and not all of it
NWBO
Twilson Twilson 12 minutes ago
Why would he think fed will do a surprise cut?
B-100 B-100 12 minutes ago
I need $11 per share just to break even ....I image some of you are in the same gyro plane.
B-100 B-100 12 minutes ago
I need $11 per share just to break even ....I image some of you are in the same gyro plane.
Jwizzz Jwizzz 12 minutes ago
I thnk the next podcast could include an update on TheAlley, 30 days ago, they vow to signed up 1M users in 30 days.Great site btw, and unlike Coinbase with 1%fee, its all free for users and merchant!
NSAV

Your Recent History

Delayed Upgrade Clock